Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperoxaluria, Primary | 3 | 2024 | 24 | 1.930 |
Why?
|
Cystinuria | 3 | 2020 | 19 | 1.030 |
Why?
|
Hyperoxaluria | 2 | 2022 | 32 | 1.000 |
Why?
|
Spinal Dysraphism | 7 | 2022 | 178 | 0.890 |
Why?
|
Nephrolithiasis | 6 | 2024 | 116 | 0.860 |
Why?
|
Urinary Tract | 4 | 2021 | 313 | 0.830 |
Why?
|
Kidney Tubules, Collecting | 5 | 2017 | 162 | 0.620 |
Why?
|
Urologic Diseases | 1 | 2019 | 247 | 0.540 |
Why?
|
Renal Replacement Therapy | 8 | 2012 | 282 | 0.540 |
Why?
|
Sodium | 2 | 2011 | 1588 | 0.530 |
Why?
|
Glomerulosclerosis, Focal Segmental | 3 | 2004 | 335 | 0.490 |
Why?
|
Urinary Bladder, Neurogenic | 3 | 2021 | 173 | 0.440 |
Why?
|
Urogenital Abnormalities | 3 | 2021 | 261 | 0.420 |
Why?
|
Kidney Cortex | 1 | 2011 | 169 | 0.390 |
Why?
|
Nephrocalcinosis | 3 | 2017 | 52 | 0.390 |
Why?
|
Kidney Transplantation | 7 | 2024 | 4235 | 0.380 |
Why?
|
Meningomyelocele | 2 | 2021 | 171 | 0.330 |
Why?
|
Urolithiasis | 2 | 2022 | 125 | 0.300 |
Why?
|
Oxalates | 3 | 2022 | 98 | 0.300 |
Why?
|
Kidney Calculi | 2 | 2022 | 463 | 0.270 |
Why?
|
Denys-Drash Syndrome | 1 | 2005 | 7 | 0.260 |
Why?
|
Aquaporins | 3 | 2003 | 174 | 0.240 |
Why?
|
Diarrhea | 1 | 2011 | 1318 | 0.240 |
Why?
|
Wilms Tumor | 1 | 2005 | 379 | 0.200 |
Why?
|
Receptors, Purinergic P2 | 1 | 2022 | 150 | 0.190 |
Why?
|
Infant | 21 | 2021 | 36193 | 0.190 |
Why?
|
Graft Survival | 5 | 2019 | 3820 | 0.190 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4740 | 0.180 |
Why?
|
Renal Dialysis | 4 | 2024 | 1796 | 0.170 |
Why?
|
Living Donors | 2 | 2002 | 641 | 0.170 |
Why?
|
Kidney Function Tests | 2 | 2020 | 679 | 0.170 |
Why?
|
Kidney | 6 | 2021 | 7048 | 0.170 |
Why?
|
Acidosis, Renal Tubular | 1 | 2019 | 50 | 0.170 |
Why?
|
Early Diagnosis | 1 | 2024 | 1186 | 0.160 |
Why?
|
Child | 27 | 2022 | 80158 | 0.160 |
Why?
|
Pedigree | 4 | 2020 | 4542 | 0.160 |
Why?
|
Cations, Divalent | 1 | 1998 | 168 | 0.160 |
Why?
|
Vesico-Ureteral Reflux | 2 | 2021 | 437 | 0.150 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2019 | 195 | 0.150 |
Why?
|
Body Water | 1 | 1998 | 340 | 0.140 |
Why?
|
Minerals | 1 | 1998 | 283 | 0.140 |
Why?
|
Hypertension, Renovascular | 1 | 1997 | 116 | 0.140 |
Why?
|
RNA Interference | 2 | 2022 | 2832 | 0.140 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
Child, Preschool | 20 | 2022 | 42232 | 0.130 |
Why?
|
Forkhead Transcription Factors | 2 | 2020 | 1616 | 0.130 |
Why?
|
Infant, Newborn | 13 | 2021 | 26202 | 0.130 |
Why?
|
Antibiotic Prophylaxis | 1 | 2021 | 637 | 0.130 |
Why?
|
Anion Transport Proteins | 1 | 2016 | 141 | 0.130 |
Why?
|
Marfan Syndrome | 1 | 1997 | 236 | 0.120 |
Why?
|
Dietary Proteins | 2 | 2011 | 952 | 0.120 |
Why?
|
Mutation | 6 | 2020 | 30053 | 0.120 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 802 | 0.120 |
Why?
|
Neurofibromatoses | 1 | 2018 | 299 | 0.110 |
Why?
|
Nephrotic Syndrome | 1 | 2017 | 390 | 0.110 |
Why?
|
Humans | 46 | 2024 | 761596 | 0.110 |
Why?
|
Ion Channels | 1 | 1998 | 1040 | 0.110 |
Why?
|
Adolescent | 19 | 2020 | 88326 | 0.110 |
Why?
|
Urologic Surgical Procedures | 1 | 2015 | 298 | 0.110 |
Why?
|
Epithelium | 1 | 2017 | 1603 | 0.100 |
Why?
|
Tumor Lysis Syndrome | 1 | 2012 | 38 | 0.100 |
Why?
|
Liver Transplantation | 1 | 2024 | 2330 | 0.100 |
Why?
|
Amiloride | 1 | 2011 | 116 | 0.100 |
Why?
|
Diet, Protein-Restricted | 1 | 2011 | 73 | 0.100 |
Why?
|
Microvilli | 1 | 2011 | 234 | 0.090 |
Why?
|
Male | 30 | 2022 | 360846 | 0.090 |
Why?
|
Female | 27 | 2022 | 392705 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2016 | 1440 | 0.090 |
Why?
|
Metabolism, Inborn Errors | 1 | 2012 | 284 | 0.090 |
Why?
|
Kidney Medulla | 2 | 2001 | 169 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
Population Surveillance | 1 | 2020 | 2598 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 17904 | 0.080 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2009 | 109 | 0.080 |
Why?
|
Urodynamics | 2 | 2021 | 346 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 5 | 2011 | 8181 | 0.080 |
Why?
|
Diuretics | 1 | 2011 | 610 | 0.080 |
Why?
|
Kidney Neoplasms | 1 | 2005 | 4251 | 0.080 |
Why?
|
Kidney Diseases | 2 | 2012 | 2091 | 0.080 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2011 | 389 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2022 | 12341 | 0.080 |
Why?
|
Graft Rejection | 4 | 2019 | 4446 | 0.070 |
Why?
|
Biological Transport | 1 | 2011 | 2091 | 0.070 |
Why?
|
Nutritional Support | 1 | 2008 | 173 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1998 | 3612 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8633 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3801 | 0.070 |
Why?
|
Aldosterone | 1 | 2011 | 870 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2019 | 64685 | 0.070 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2011 | 2496 | 0.070 |
Why?
|
Registries | 6 | 2020 | 8225 | 0.070 |
Why?
|
Fetal Development | 1 | 2011 | 769 | 0.070 |
Why?
|
Aquaporin 6 | 3 | 2003 | 44 | 0.070 |
Why?
|
Recurrence | 3 | 2004 | 8466 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2001 | 0.060 |
Why?
|
Citric Acid | 1 | 2005 | 123 | 0.060 |
Why?
|
Aquaporin 2 | 3 | 2003 | 126 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2242 | 0.060 |
Why?
|
DNA Mutational Analysis | 3 | 2019 | 4111 | 0.060 |
Why?
|
Dogfish | 1 | 2003 | 11 | 0.060 |
Why?
|
Prospective Studies | 7 | 2021 | 54423 | 0.060 |
Why?
|
Dihydrotachysterol | 1 | 2003 | 4 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2011 | 17635 | 0.060 |
Why?
|
Rats | 5 | 2011 | 23741 | 0.050 |
Why?
|
Algorithms | 1 | 2024 | 14033 | 0.050 |
Why?
|
Membranes, Artificial | 1 | 2005 | 366 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9610 | 0.050 |
Why?
|
Animals | 12 | 2022 | 168475 | 0.050 |
Why?
|
Calpain | 1 | 2003 | 146 | 0.050 |
Why?
|
Calcium Oxalate | 1 | 2022 | 75 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.050 |
Why?
|
Multiple Organ Failure | 1 | 2005 | 387 | 0.050 |
Why?
|
Adult | 12 | 2021 | 221210 | 0.050 |
Why?
|
Kidney Failure, Chronic | 1 | 2014 | 2472 | 0.050 |
Why?
|
Calcium-Binding Proteins | 2 | 2003 | 1069 | 0.050 |
Why?
|
MicroRNAs | 1 | 2017 | 3816 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 59260 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3530 | 0.050 |
Why?
|
Energy Intake | 1 | 2008 | 2134 | 0.050 |
Why?
|
Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
Transcription Factors | 1 | 2020 | 12130 | 0.050 |
Why?
|
Calcineurin | 1 | 2001 | 229 | 0.050 |
Why?
|
beta Carotene | 1 | 2022 | 523 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3032 | 0.040 |
Why?
|
Base Sequence | 1 | 2011 | 12441 | 0.040 |
Why?
|
Hostility | 1 | 2021 | 183 | 0.040 |
Why?
|
Cystine | 1 | 2020 | 94 | 0.040 |
Why?
|
Mutation, Missense | 2 | 2022 | 2571 | 0.040 |
Why?
|
Chloride-Bicarbonate Antiporters | 1 | 2019 | 103 | 0.040 |
Why?
|
Magnesium | 1 | 2003 | 804 | 0.040 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 1 | 2019 | 150 | 0.040 |
Why?
|
Prognosis | 4 | 2019 | 29629 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 484 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1600 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2011 | 2518 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2022 | 529 | 0.040 |
Why?
|
Mice | 5 | 2022 | 81539 | 0.040 |
Why?
|
Calcium | 3 | 2022 | 5722 | 0.040 |
Why?
|
Larva | 1 | 2020 | 508 | 0.040 |
Why?
|
Aquaporin 3 | 1 | 1998 | 14 | 0.040 |
Why?
|
Arginine Vasopressin | 1 | 1998 | 125 | 0.040 |
Why?
|
Xenopus | 1 | 2020 | 711 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2018 | 2735 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2000 | 691 | 0.040 |
Why?
|
Receptors, Vasopressin | 1 | 1998 | 106 | 0.040 |
Why?
|
Potassium | 1 | 2022 | 1311 | 0.040 |
Why?
|
Hypertension | 1 | 2018 | 8540 | 0.040 |
Why?
|
Immunoblotting | 2 | 2016 | 1646 | 0.040 |
Why?
|
Heparin | 1 | 2005 | 1634 | 0.040 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2017 | 85 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 1998 | 420 | 0.040 |
Why?
|
Heredity | 1 | 2017 | 148 | 0.040 |
Why?
|
Homeostasis | 2 | 2017 | 3323 | 0.030 |
Why?
|
Vasopressins | 1 | 1998 | 351 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 1998 | 575 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2011 | 12794 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 2008 | 1924 | 0.030 |
Why?
|
Cohort Studies | 5 | 2019 | 41495 | 0.030 |
Why?
|
Urea | 1 | 1998 | 443 | 0.030 |
Why?
|
Phenotype | 3 | 2018 | 16592 | 0.030 |
Why?
|
Ureter | 1 | 1998 | 368 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2017 | 279 | 0.030 |
Why?
|
Kidney Tubules, Proximal | 1 | 2017 | 383 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13446 | 0.030 |
Why?
|
Hypercalcemia | 1 | 1998 | 423 | 0.030 |
Why?
|
Bicarbonates | 1 | 2016 | 292 | 0.030 |
Why?
|
Sulfates | 1 | 2016 | 380 | 0.030 |
Why?
|
Aorta, Abdominal | 1 | 2018 | 625 | 0.030 |
Why?
|
Down-Regulation | 2 | 2017 | 2919 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2017 | 384 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3639 | 0.030 |
Why?
|
Urography | 1 | 2015 | 316 | 0.030 |
Why?
|
Ureteroscopy | 1 | 2015 | 146 | 0.030 |
Why?
|
Endosomes | 3 | 2003 | 522 | 0.030 |
Why?
|
Ultrasonography | 2 | 2017 | 5971 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2008 | 15633 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2020 | 14417 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2787 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2020 | 1152 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 22176 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2280 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10090 | 0.030 |
Why?
|
Glycosylation | 1 | 2016 | 1097 | 0.030 |
Why?
|
Hemodialysis Solutions | 1 | 2012 | 7 | 0.030 |
Why?
|
Risk Factors | 4 | 2022 | 74213 | 0.030 |
Why?
|
Animals, Newborn | 1 | 1998 | 2677 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 738 | 0.030 |
Why?
|
Protein Folding | 1 | 2016 | 870 | 0.020 |
Why?
|
Protein Binding | 2 | 2020 | 9353 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2748 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1200 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2467 | 0.020 |
Why?
|
Water | 1 | 1998 | 1411 | 0.020 |
Why?
|
Epitopes | 1 | 1998 | 2503 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3267 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21355 | 0.020 |
Why?
|
Survival Rate | 3 | 2014 | 12723 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2601 | 0.020 |
Why?
|
United States | 5 | 2020 | 72340 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12973 | 0.020 |
Why?
|
Alleles | 1 | 2021 | 6864 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3306 | 0.020 |
Why?
|
Fibrosis | 1 | 2017 | 2049 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1967 | 0.020 |
Why?
|
Retrospective Studies | 5 | 2020 | 80647 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3124 | 0.020 |
Why?
|
Antibodies | 1 | 1998 | 2418 | 0.020 |
Why?
|
Pregnancy | 1 | 2011 | 29890 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2002 | 4176 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2019 | 1860 | 0.020 |
Why?
|
Family | 1 | 2020 | 3195 | 0.020 |
Why?
|
Anticoagulants | 1 | 2005 | 4812 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1998 | 2822 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1898 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2000 | 4431 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 4937 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3968 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1638 | 0.020 |
Why?
|
Hemofiltration | 1 | 2008 | 59 | 0.020 |
Why?
|
Age Factors | 1 | 2004 | 18399 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 23996 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2927 | 0.020 |
Why?
|
Critical Illness | 2 | 2009 | 2723 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9327 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3537 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7581 | 0.010 |
Why?
|
Diet | 1 | 2022 | 8075 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20568 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15601 | 0.010 |
Why?
|
Leupeptins | 1 | 2003 | 113 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14665 | 0.010 |
Why?
|
Immune Sera | 1 | 2003 | 606 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12990 | 0.010 |
Why?
|
Caseins | 1 | 2003 | 104 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2003 | 188 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2022 | 18255 | 0.010 |
Why?
|
Trypsin | 1 | 2003 | 495 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2001 | 10 | 0.010 |
Why?
|
Demography | 1 | 2007 | 1648 | 0.010 |
Why?
|
Nephrons | 1 | 2003 | 168 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 2001 | 175 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2003 | 5870 | 0.010 |
Why?
|
Graft Occlusion, Vascular | 1 | 2005 | 537 | 0.010 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2008 | 1017 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15266 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2003 | 1060 | 0.010 |
Why?
|
Dextrans | 1 | 2003 | 574 | 0.010 |
Why?
|
Autoradiography | 1 | 2001 | 728 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15843 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13510 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9647 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2008 | 6228 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2015 | 39106 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2003 | 11076 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1741 | 0.010 |
Why?
|
Aging | 1 | 1998 | 8710 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 7968 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15733 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5872 | 0.010 |
Why?
|
Signal Transduction | 1 | 2001 | 23447 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2001 | 1791 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20100 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2001 | 1202 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12059 | 0.010 |
Why?
|
Hemorrhage | 1 | 2005 | 3424 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2000 | 4807 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10766 | 0.010 |
Why?
|
Phosphorylation | 1 | 2001 | 8321 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 1998 | 2178 | 0.010 |
Why?
|
Chronic Disease | 1 | 2000 | 9319 | 0.000 |
Why?
|
Middle Aged | 1 | 2014 | 220921 | 0.000 |
Why?
|